TITLE
Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study

ORGANISM
Homo sapiens

SUMMARY
Microarray analysis of transcriptional changes in biopsies of solid tumors from patients treated in a Phase I study with the Cdk inhibitor PHA-793887.

DESIGN
7 patient biopsies pre- and post-treatment in dye swap. Tumors are of different origins, and are described in the accompanying manuscript.

PLATFORM
GPL6480 Agilent-014850 Whole Human Genome Microarray 4x44K G4112F (Probe Name version)

CITATIONS
20423997

